tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksFDA CalendarMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

INCY Stock Latest News

Knight Therapeutics announces NIKTIMVO regulatory submission in Brazil
The FlyKnight Therapeutics announces NIKTIMVO regulatory submission in Brazil
4d ago
INCY
Incyte price target raised to $117 from $116 at Barclays
PremiumThe Fly
Incyte price target raised to $117 from $116 at Barclays
4d ago
INCY
Incyte’s Profit Outlook Threatened by Emerging U.S. ‘Most Favored Nation’ Drug Pricing Policies
PremiumCompany Announcements
Incyte’s Profit Outlook Threatened by Emerging U.S. ‘Most Favored Nation’ Drug Pricing Policies
10d ago
INCY
Incyte price target raised to $102 from $94 at Morgan Stanley
PremiumThe Fly
Incyte price target raised to $102 from $94 at Morgan Stanley
11d ago
INCY
Incyte price target raised to $120 from $119 at Stifel
PremiumThe Fly
Incyte price target raised to $120 from $119 at Stifel
11d ago
INCY
Incyte: Long-Term Revenue Durability and Underappreciated Pipeline Support Buy Rating and $135 Target
PremiumRatingsIncyte: Long-Term Revenue Durability and Underappreciated Pipeline Support Buy Rating and $135 Target
11d ago
INCY
Incyte Earnings Call Highlights Growth Beyond Jakafi
Premium
Company Announcements
Incyte Earnings Call Highlights Growth Beyond Jakafi
11d ago
INCY
Morning Movers: Fiserv and Spotify jump following fourth quarter results
Premium
The Fly
Morning Movers: Fiserv and Spotify jump following fourth quarter results
12d ago
KO
ON
Incyte sees FY26 product revenue $4.77B-$4.94B
PremiumThe Fly
Incyte sees FY26 product revenue $4.77B-$4.94B
12d ago
INCY
Incyte reports Q4 EPS $1.80, consensus $1.92
PremiumThe Fly
Incyte reports Q4 EPS $1.80, consensus $1.92
12d ago
INCY
Notable companies reporting before tomorrow’s open
PremiumThe Fly
Notable companies reporting before tomorrow’s open
13d ago
KO
CVS
INCY Earnings Report this Week: Is It a Buy, Ahead of Earnings?
PremiumPre-Earnings
INCY Earnings Report this Week: Is It a Buy, Ahead of Earnings?
14d ago
INCY
Incyte price target raised to $110 from $102 at Piper Sandler
PremiumThe FlyIncyte price target raised to $110 from $102 at Piper Sandler
16d ago
INCY
Microsoft downgraded, Snap upgraded: Wall Street’s top analyst calls
Premium
The Fly
Microsoft downgraded, Snap upgraded: Wall Street’s top analyst calls
17d ago
CE
ZM
Incyte: Market Overpenalizes Jakafi LOE as Diversified Pipeline and Emerging Franchises Support Buy Rating and $135 Target
Premium
Ratings
Incyte: Market Overpenalizes Jakafi LOE as Diversified Pipeline and Emerging Franchises Support Buy Rating and $135 Target
17d ago
INCY
Incyte initiated with a Buy at H.C. Wainwright
PremiumThe Fly
Incyte initiated with a Buy at H.C. Wainwright
17d ago
INCY
Tafasitamab-Parsaclisib Trial Termination Tempers Incyte Outlook
PremiumCompany Announcements
Tafasitamab-Parsaclisib Trial Termination Tempers Incyte Outlook
18d ago
INCY
Incyte price target raised to $116 from $115 at Barclays
PremiumThe Fly
Incyte price target raised to $116 from $115 at Barclays
18d ago
INCY
Incyte announces CHMP opinion recommending approval of Zynyz combination
PremiumThe Fly
Incyte announces CHMP opinion recommending approval of Zynyz combination
23d ago
INCY
Intel upgraded, Domino’s downgraded: Wall Street’s top analyst calls
PremiumThe FlyIntel upgraded, Domino’s downgraded: Wall Street’s top analyst calls
1M ago
CE
CVX
Wells downgrades Incyte to Equal Weight on lack of catalysts
Premium
The Fly
Wells downgrades Incyte to Equal Weight on lack of catalysts
1M ago
INCY
Incyte downgraded to Equal Weight from Overweight at Wells Fargo
Premium
The Fly
Incyte downgraded to Equal Weight from Overweight at Wells Fargo
1M ago
INCY

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >